BMO Resumes Coverage On Tricon Residential After US IPO

Earlier this month, Tricon Residential (TSX: TCN) announced that they closed their U.S. IPO selling 46,248,746 shares for total proceeds of US$570 million, and completed their listing on the NYSE under the ticker “TCN”. Additionally, Tricon offered a private placement of shares to Blackstone Real Estate Investment Trust.

After the news, many analysts raised their 12-month price targets. The new 12-month price target sits at C$17.38. There are 8 analysts covering the stock with 2 having strong buy ratings and the other 6 have buys. The street high sits at C$19 from BMO Capital Markets while the lowest comes in at C$15.25.

BMO Capital Markets resumed their coverage with an outperform rating on Tricon Residential after the IPO and raised their 12-month price target to C$19 from C$18. They write, “We believe Tricon has a multi-year opportunity for FFO and BVPS growth while leveraging third-party fee-bearing equity capital and reducing leverage.”

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

BMO says that the net proceeds will be used to repay the amount outstanding under its pass-through certificates and the leftover money will be used to purchase future SFR JV-2 homes.

Below you can see BMO’s updated 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold & Copper Stocks Everyone Keeps Asking About | Oct. 12-16 – Weekly Mining Mailbag

Similar Gold Mines Are Valued 10X Higher. Why Not This One? | JW Dumont – Granada Gold Mine

The US Interest Bill Gold Can’t Ignore | Peter Grandich

Recommended

Cambria’s Silver Coin Infill Program Delivers 98.56 g/t Gold Over 8.2 Metres

First Majestic Produces 3.4 Million Ounces of Silver in Q3 2026, Jerritt Canyon Restart Remains on Track

Related News

Kinross Gold: Canaccord Lowers Target To $10.50

On February 16th, Kinross Gold Corp (TSX: K) put out a number of news releases,...

Thursday, February 24, 2022, 04:52:00 PM

Canaccord Drops Antibe’s Price Target To $0.70 Following Asset Sale

Antibe Therapeutics Inc. (TSX: ATE) recently reported their full-year 2022 results, wherein the company reported...

Friday, July 15, 2022, 02:25:00 PM

Canaccord Initiates Coverage On Else Nutrition With C$6.50 Price Target

This morning, Canaccord Genuity initiated coverage on Else Nutrition (TSXV: BABY) with a C$6.50 price...

Monday, December 7, 2020, 04:26:00 PM

Antibe: Canaccord Lowers Price Target After Co-Leading $40.4 Million Financing

Wednesday, Antibe Therapeutics (TSX: ATE) announced that they closed their bought deal financing. The bought...

Friday, February 26, 2021, 11:55:00 AM

Great Bear Resources Sees Canaccord Bump Price Target To Buyout Figure Of $29

On December 8th, Kinross (TSX: K) announced it would be acquiring Great Bear Resources (TSXV:...

Sunday, December 19, 2021, 11:14:00 AM